United States Intravenous (IV) Iron Drugs Market Report 2017

United States Intravenous (IV) Iron Drugs Market Report 2017

1 Intravenous (IV) Iron Drugs Overview

1.1 Product Overview and Scope of Intravenous (IV) Iron Drugs

1.2 Classification of Intravenous (IV) Iron Drugs

1.2.1 Type I

1.2.2 Type II

1.3 Application of Intravenous (IV) Iron Drugs

1.3.1 Application 1

1.3.2 Application 2

1.4 United States Market Size Sales (Volume) and Revenue (Value) of Intravenous (IV) Iron Drugs (2012-2022)

1.4.1 United States Intravenous (IV) Iron Drugs Sales and Growth Rate (2012-2022)

1.4.2 United States Intravenous (IV) Iron Drugs Revenue and Growth Rate (2012-2022)

2 United States Intravenous (IV) Iron Drugs Competition by Manufacturers

2.1 United States Intravenous (IV) Iron Drugs Sales and Market Share of Key Manufacturers (2015 and 2016)

2.2 United States Intravenous (IV) Iron Drugs Revenue and Share by Manufactures (2015 and 2016)

2.3 United States Intravenous (IV) Iron Drugs Average Price by Manufactures (2015 and 2016)

2.4 Intravenous (IV) Iron Drugs Market Competitive Situation and Trends

2.4.1 Intravenous (IV) Iron Drugs Market Concentration Rate

2.4.2 Intravenous (IV) Iron Drugs Market Share of Top 3 and Top 5 Manufacturers

2.4.3 Mergers & Acquisitions, Expansion

3 United States Intravenous (IV) Iron Drugs Sales (Volume) and Revenue (Value) by States (2012-2017)

3.1 United States Intravenous (IV) Iron Drugs Sales and Market Share by States (2012-2017)

3.2 United States Intravenous (IV) Iron Drugs Revenue and Market Share by States (2012-2017)

3.3 United States Intravenous (IV) Iron Drugs Price by States (2012-2017)

4 United States Intravenous (IV) Iron Drugs Sales (Volume) and Revenue (Value) by Type (2012-2017)

4.1 United States Intravenous (IV) Iron Drugs Sales and Market Share by Type (2012-2017)

4.2 United States Intravenous (IV) Iron Drugs Revenue and Market Share by Type (2012-2017)

4.3 United States Intravenous (IV) Iron Drugs Price by Type (2012-2017)

4.4 United States Intravenous (IV) Iron Drugs Sales Growth Rate by Type (2012-2017)

5 United States Intravenous (IV) Iron Drugs Sales (Volume) by Application (2012-2017)

5.1 United States Intravenous (IV) Iron Drugs Sales and Market Share by Application (2012-2017)

5.2 United States Intravenous (IV) Iron Drugs Sales Growth Rate by Application (2012-2017)

5.3 Market Drivers and Opportunities

6 United States Intravenous (IV) Iron Drugs Manufacturers Profiles/Analysis

6.1 AMAG Pharmaceuticals

6.1.1 Company Basic Information, Manufacturing Base and Competitors

6.1.2 Intravenous (IV) Iron Drugs Product Type, Application and Specification

6.1.2.1 Product A

6.1.2.2 Product B

6.1.3 AMAG Pharmaceuticals Intravenous (IV) Iron Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

6.1.4 Main Business/Business Overview

6.2 Actavis

6.2.2 Intravenous (IV) Iron Drugs Product Type, Application and Specification

6.2.2.1 Product A

6.2.2.2 Product B

6.2.3 Actavis Intravenous (IV) Iron Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

6.2.4 Main Business/Business Overview

6.3 Galenica

6.3.2 Intravenous (IV) Iron Drugs Product Type, Application and Specification

6.3.2.1 Product A

6.3.2.2 Product B

6.3.3 Galenica Intravenous (IV) Iron Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

6.3.4 Main Business/Business Overview

6.4 Vifor Pharma

6.4.2 Intravenous (IV) Iron Drugs Product Type, Application and Specification

6.4.2.1 Product A

6.4.2.2 Product B

6.4.3 Vifor Pharma Intravenous (IV) Iron Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

6.4.4 Main Business/Business Overview

6.5 Luitpold Pharmaceuticals

6.5.2 Intravenous (IV) Iron Drugs Product Type, Application and Specification

6.5.2.1 Product A

6.5.2.2 Product B

6.5.3 Luitpold Pharmaceuticals Intravenous (IV) Iron Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

6.5.4 Main Business/Business Overview

6.6 Pharmacosmos A/S

6.6.2 Intravenous (IV) Iron Drugs Product Type, Application and Specification

6.6.2.1 Product A

6.6.2.2 Product B

6.6.3 Pharmacosmos A/S Intravenous (IV) Iron Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

6.6.4 Main Business/Business Overview

6.7 American Regent

6.7.2 Intravenous (IV) Iron Drugs Product Type, Application and Specification

6.7.2.1 Product A

6.7.2.2 Product B

6.7.3 American Regent Intravenous (IV) Iron Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

6.7.4 Main Business/Business Overview

6.8 Fresenius Medical Care AG & Co. KGaA

6.8.2 Intravenous (IV) Iron Drugs Product Type, Application and Specification

6.8.2.1 Product A

6.8.2.2 Product B

6.8.3 Fresenius Medical Care AG & Co. KGaA Intravenous (IV) Iron Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

6.8.4 Main Business/Business Overview

6.9 Anofi US

6.9.2 Intravenous (IV) Iron Drugs Product Type, Application and Specification

6.9.2.1 Product A

6.9.2.2 Product B

6.9.3 Anofi US Intravenous (IV) Iron Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

6.9.4 Main Business/Business Overview

6.10 Takeda Pharmaceutical

6.10.2 Intravenous (IV) Iron Drugs Product Type, Application and Specification

6.10.2.1 Product A

6.10.2.2 Product B

6.10.3 Takeda Pharmaceutical Intravenous (IV) Iron Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

6.10.4 Main Business/Business Overview

7 Intravenous (IV) Iron Drugs Manufacturing Cost Analysis

7.1 Intravenous (IV) Iron Drugs Key Raw Materials Analysis

7.1.1 Key Raw Materials

7.1.2 Price Trend of Key Raw Materials

7.1.3 Key Suppliers of Raw Materials

7.1.4 Market Concentration Rate of Raw Materials

7.2 Proportion of Manufacturing Cost Structure

7.2.1 Raw Materials

7.2.2 Labor Cost

7.2.3 Manufacturing Expenses

7.3 Manufacturing Process Analysis of Intravenous (IV) Iron Drugs

8 Industrial Chain, Sourcing Strategy and Downstream Buyers

8.1 Intravenous (IV) Iron Drugs Industrial Chain Analysis

8.2 Upstream Raw Materials Sourcing

8.3 Raw Materials Sources of Intravenous (IV) Iron Drugs Major Manufacturers in 2015

8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders

9.1 Marketing Channel

9.1.1 Direct Marketing

9.1.2 Indirect Marketing

9.1.3 Marketing Channel Development Trend

9.2 Market Positioning

9.2.1 Pricing Strategy

9.2.2 Brand Strategy

9.2.3 Target Client

9.3 Distributors/Traders List

10 Market Effect Factors Analysis

10.1 Technology Progress/Risk

10.1.1 Substitutes Threat

10.1.2 Technology Progress in Related Industry

10.2 Consumer Needs/Customer Preference Change

10.3 Economic/Political Environmental Change

11 United States Intravenous (IV) Iron Drugs Market Forecast (2017-2022)

11.1 United States Intravenous (IV) Iron Drugs Sales, Revenue Forecast (2017-2022)

11.2 United States Intravenous (IV) Iron Drugs Sales Forecast by Type (2017-2022)

11.3 United States Intravenous (IV) Iron Drugs Sales Forecast by Application (2017-2022)

11.4 Intravenous (IV) Iron Drugs Price Forecast (2017-2022)

12 Research Findings and Conclusion

13 Appendix

Methodology

Analyst Introduction

Data Source

Figure Picture of Intravenous (IV) Iron Drugs

Table Classification of Intravenous (IV) Iron Drugs

Figure United States Sales Market Share of Intravenous (IV) Iron Drugs by Type in 2015

Table Application of Intravenous (IV) Iron Drugs

Figure United States Sales Market Share of Intravenous (IV) Iron Drugs by Application in 2015

Figure United States Intravenous (IV) Iron Drugs Sales and Growth Rate (2012-2022)

Figure United States Intravenous (IV) Iron Drugs Revenue and Growth Rate (2012-2022)

Table United States Intravenous (IV) Iron Drugs Sales of Key Manufacturers (2015 and 2016)

Table United States Intravenous (IV) Iron Drugs Sales Share by Manufacturers (2015 and 2016)

Figure 2015 Intravenous (IV) Iron Drugs Sales Share by Manufacturers

Figure 2016 Intravenous (IV) Iron Drugs Sales Share by Manufacturers

Table United States Intravenous (IV) Iron Drugs Revenue by Manufacturers (2015 and 2016)

Table United States Intravenous (IV) Iron Drugs Revenue Share by Manufacturers (2015 and 2016)

Table 2015 United States Intravenous (IV) Iron Drugs Revenue Share by Manufacturers

Table 2016 United States Intravenous (IV) Iron Drugs Revenue Share by Manufacturers

Table United States Market Intravenous (IV) Iron Drugs Average Price of Key Manufacturers (2015 and 2016)

Figure United States Market Intravenous (IV) Iron Drugs Average Price of Key Manufacturers in 2015

Figure Intravenous (IV) Iron Drugs Market Share of Top 3 Manufacturers

Figure Intravenous (IV) Iron Drugs Market Share of Top 5 Manufacturers

Table United States Intravenous (IV) Iron Drugs Sales by States (2012-2017)

Table United States Intravenous (IV) Iron Drugs Sales Share by States (2012-2017)

Figure United States Intravenous (IV) Iron Drugs Sales Market Share by States in 2015

Table United States Intravenous (IV) Iron Drugs Revenue and Market Share by States (2012-2017)

Table United States Intravenous (IV) Iron Drugs Revenue Share by States (2012-2017)

Figure Revenue Market Share of Intravenous (IV) Iron Drugs by States (2012-2017)

Table United States Intravenous (IV) Iron Drugs Price by States (2012-2017)

Table United States Intravenous (IV) Iron Drugs Sales by Type (2012-2017)

Table United States Intravenous (IV) Iron Drugs Sales Share by Type (2012-2017)

Figure United States Intravenous (IV) Iron Drugs Sales Market Share by Type in 2015

Table United States Intravenous (IV) Iron Drugs Revenue and Market Share by Type (2012-2017)

Table United States Intravenous (IV) Iron Drugs Revenue Share by Type (2012-2017)

Figure Revenue Market Share of Intravenous (IV) Iron Drugs by Type (2012-2017)

Table United States Intravenous (IV) Iron Drugs Price by Type (2012-2017)

Figure United States Intravenous (IV) Iron Drugs Sales Growth Rate by Type (2012-2017)

Table United States Intravenous (IV) Iron Drugs Sales by Application (2012-2017)

Table United States Intravenous (IV) Iron Drugs Sales Market Share by Application (2012-2017)

Figure United States Intravenous (IV) Iron Drugs Sales Market Share by Application in 2015

Table United States Intravenous (IV) Iron Drugs Sales Growth Rate by Application (2012-2017)

Figure United States Intravenous (IV) Iron Drugs Sales Growth Rate by Application (2012-2017)

Table AMAG Pharmaceuticals Basic Information List

Table AMAG Pharmaceuticals Intravenous (IV) Iron Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

Figure AMAG Pharmaceuticals Intravenous (IV) Iron Drugs Sales Market Share (2012-2017)

Table Actavis Basic Information List

Table Actavis Intravenous (IV) Iron Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

Table Actavis Intravenous (IV) Iron Drugs Sales Market Share (2012-2017)

Table Galenica Basic Information List

Table Galenica Intravenous (IV) Iron Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

Table Galenica Intravenous (IV) Iron Drugs Sales Market Share (2012-2017)

Table Vifor Pharma Basic Information List

Table Vifor Pharma Intravenous (IV) Iron Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

Table Vifor Pharma Intravenous (IV) Iron Drugs Sales Market Share (2012-2017)

Table Luitpold Pharmaceuticals Basic Information List

Table Luitpold Pharmaceuticals Intravenous (IV) Iron Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

Table Luitpold Pharmaceuticals Intravenous (IV) Iron Drugs Sales Market Share (2012-2017)

Table Pharmacosmos A/S Basic Information List

Table Pharmacosmos A/S Intravenous (IV) Iron Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

Table Pharmacosmos A/S Intravenous (IV) Iron Drugs Sales Market Share (2012-2017)

Table American Regent Basic Information List

Table American Regent Intravenous (IV) Iron Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

Table American Regent Intravenous (IV) Iron Drugs Sales Market Share (2012-2017)

Table Fresenius Medical Care AG & Co. KGaA Basic Information List

Table Fresenius Medical Care AG & Co. KGaA Intravenous (IV) Iron Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

Table Fresenius Medical Care AG & Co. KGaA Intravenous (IV) Iron Drugs Sales Market Share (2012-2017)

Table Anofi US Basic Information List

Table Anofi US Intravenous (IV) Iron Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

Table Anofi US Intravenous (IV) Iron Drugs Sales Market Share (2012-2017)

Table Takeda Pharmaceutical Basic Information List

Table Takeda Pharmaceutical Intravenous (IV) Iron Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

Table Takeda Pharmaceutical Intravenous (IV) Iron Drugs Sales Market Share (2012-2017)

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Intravenous (IV) Iron Drugs

Figure Manufacturing Process Analysis of Intravenous (IV) Iron Drugs

Figure Intravenous (IV) Iron Drugs Industrial Chain Analysis

Table Raw Materials Sources of Intravenous (IV) Iron Drugs Major Manufacturers in 2015

Table Major Buyers of Intravenous (IV) Iron Drugs

Table Distributors/Traders List

Figure United States Intravenous (IV) Iron Drugs Production and Growth Rate Forecast (2017-2022)

Figure United States Intravenous (IV) Iron Drugs Revenue and Growth Rate Forecast (2017-2022)

Table United States Intravenous (IV) Iron Drugs Production Forecast by Type (2017-2022)

Table United States Intravenous (IV) Iron Drugs Consumption Forecast by Application (2017-2022)

Table United States Intravenous (IV) Iron Drugs Sales Forecast by States (2017-2022)

Table United States Intravenous (IV) Iron Drugs Sales Share Forecast by States (2017-2022)